828834554	828834554	CD	B-NP	O
|	|	NNP	I-NP	O
CH	CH	NNP	I-NP	O
|	|	VBD	B-VP	O
69046457	69046457	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
921739	921739	CD	B-NP	O
|	|	CC	I-NP	O
11/22/1999	11/22/1999	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
SEPSIS	SEPSIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/22/1999	11/22/1999	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/3/1999	1/3/1999	CD	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Sepsis	Sepsis	NNP	B-NP	O
related	related	JJ	B-ADJP	O
to	to	TO	B-PP	O
Streptococcal	Streptococcal	JJ	B-NP	B-protein
laryngitis	laryngitis	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
culture	culture	NN	I-NP	I-protein
positive	positive	JJ	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

OTHER	OTHER	NNP	B-NP	O
SIGNIFICANT	SIGNIFICANT	NNP	I-NP	O
DIAGNOSES	DIAGNOSES	NNP	I-NP	O
:	:	:	O	O
Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
heart	heart	NN	I-NP	O
transplant	transplant	NN	I-NP	O
in	in	IN	B-PP	O
1989	1989	CD	B-NP	O
for	for	IN	B-PP	O
viral	viral	JJ	B-NP	O
myocarditis	myocarditis	NN	I-NP	O
and	and	CC	I-NP	O
hypertension	hypertension	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
charming	charming	JJ	I-NP	O
28-year-old	28-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
diagnosed	diagnose	VBN	I-VP	O
with	with	IN	B-PP	O
viral	viral	JJ	B-NP	O
myocardial	myocardial	JJ	I-NP	O
myopathy	myopathy	NN	I-NP	O
in	in	IN	B-PP	O
8/2	8/2	CD	B-NP	O
and	and	CC	O	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
transplant	transplant	NN	I-NP	O
at	at	IN	B-PP	O
Onfu	Onfu	NNP	B-NP	O
Mauchildin	Mauchildin	NNP	I-NP	O
Tinley	Tinley	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
very	very	RB	B-ADVP	O
well	well	RB	I-ADVP	O
with	with	IN	B-PP	O
only	only	RB	B-NP	O
one	one	CD	I-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
rejection	rejection	NN	B-NP	O
in	in	IN	B-PP	O
1995	1995	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
OKT-3	OKT-3	NN	B-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
successfully	successfully	RB	B-ADVP	O
carried	carry	VBD	B-VP	O
out	out	RP	B-PRT	O
a	a	DT	B-NP	O
pregnancy	pregnancy	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
husband	husband	NN	I-NP	O
reports	report	VBZ	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
began	begin	VBD	B-VP	O
complaining	complain	VBG	I-VP	O
of	of	IN	B-PP	O
sore	sore	NN	B-NP	O
throat	throat	NN	I-NP	O
approximately	approximately	RB	B-NP	O
two	two	CD	I-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
then	then	RB	O	O
one	one	CD	B-NP	O
day	day	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
developed	develop	VBD	B-VP	O
fever	fever	NN	B-NP	O
in	in	IN	B-PP	O
early	early	JJ	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
102.2	102.2	CD	B-NP	O
with	with	IN	B-PP	O
myalgias	myalgia	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
poor	poor	JJ	B-NP	O
p.o.	p.o.	FW	I-NP	O
intake	intake	FW	I-NP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
weekend	weekend	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
nausea	nausea	NN	I-NP	O
and	and	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
but	but	CC	O	O
developed	develop	VBD	B-VP	O
some	some	DT	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
however	however	RB	B-ADVP	O
,	,	,	O	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
with	with	IN	B-PP	O
loose	loose	JJ	B-NP	O
stools	stool	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
blood	blood	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
felt	feel	VBD	B-VP	O
dizzy	dizzy	JJ	B-NP	O
and	and	CC	I-NP	O
weak	weak	JJ	I-NP	O
today	today	NN	B-NP	O
while	while	IN	B-SBAR	O
getting	get	VBG	B-VP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
car	car	NN	I-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
took	take	VBD	B-VP	O
over-the-counter	over-the-counter	JJ	B-NP	O
medications	medication	NNS	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
daughter	daughter	NN	I-NP	O
was	be	VBD	B-VP	O
ill	ill	VBG	I-VP	O
approximately	approximately	RB	B-NP	O
two	two	CD	I-NP	O
months	month	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
works	work	VBZ	B-VP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
child	child	NN	I-NP	O
day	day	NN	I-NP	O
care	care	NN	I-NP	O
center	center	NN	I-NP	O
where	where	WRB	B-ADVP	O
many	many	JJ	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
children	child	NNS	I-NP	O
are	be	VBP	B-VP	O
ill	ill	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
lower	low	JJR	I-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
dysuria	dysuria	NN	I-NP	O
or	or	CC	I-NP	O
hematuria	hematuria	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
cough	cough	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
recent	recent	JJ	I-NP	O
travel	travel	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
diffuse	diffuse	JJ	I-NP	O
headache	headache	NN	I-NP	O
without	without	IN	B-PP	O
nystagmus	nystagmus	NN	B-NP	O
or	or	CC	I-NP	O
photophobia	photophobia	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
,	,	,	O	O
temperature	temperature	NN	B-NP	B-protein
99.1	99.1	CD	I-NP	I-protein
,	,	,	O	O
but	but	CC	O	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
hypotensive	hypotensive	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
71/33	71/33	CD	B-NP	O
,	,	,	O	O
tachycardic	tachycardic	JJ	B-ADJP	O
to	to	TO	B-PP	O
136	136	CD	B-NP	O
,	,	,	O	O
respirations	respiration	NNS	B-NP	O
of	of	IN	B-PP	O
16	16	CD	B-NP	O
and	and	CC	I-NP	O
96	96	CD	I-NP	O
%	%	NN	I-NP	O
O2	O2	NN	I-NP	O
saturated	saturate	VBN	B-VP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
received	receive	VBD	B-VP	O
two	two	CD	B-NP	O
grams	gram	NNS	I-NP	O
of	of	IN	B-PP	O
ceftriaxone	ceftriaxone	NN	B-NP	O
,	,	,	O	O
500	500	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
gram	gram	NN	I-NP	O
of	of	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
three	three	CD	B-NP	O
liters	liter	NNS	I-NP	O
of	of	IN	B-PP	O
normal	normal	JJ	B-NP	O
saline	saline	NN	I-NP	O
,	,	,	O	O
intravenous	intravenous	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
rapid	rapid	JJ	I-NP	O
infusion	infusion	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
still	still	RB	B-ADVP	O
marginal	marginal	JJ	B-ADJP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
80s	80s	CD	I-NP	O
to	to	TO	I-NP	O
90s	90s	CD	I-NP	O
systolic	systolic	JJ	I-NP	O
.	.	.	O	O

Neo	Neo	NN	B-NP	B-protein
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
at	at	IN	B-PP	O
40	40	CD	B-NP	O
mcg	mcg	NN	I-NP	O
through	through	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	O
intravenous	intravenous	JJ	I-NP	O
line	line	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Coronary	Coronary	NNP	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
previously	previously	RB	I-NP	O
mentioned	mention	VBN	I-NP	O
viral	viral	JJ	I-NP	O
myocarditis	myocarditis	NN	I-NP	O
and	and	CC	I-NP	O
heart	heart	NN	I-NP	O
transplant	transplant	NN	I-NP	O
in	in	IN	B-PP	O
1989	1989	CD	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
rejection	rejection	NN	B-NP	O
in	in	IN	B-PP	O
1995	1995	CD	B-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
OKT-3	OKT-3	NN	B-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
from	from	IN	B-PP	O
1.3	1.3	CD	B-NP	O
to	to	TO	B-PP	O
2.1	2.1	CD	B-NP	O
,	,	,	O	O
usually	usually	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
1.5	1.5	CD	I-NP	O
area	area	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
hypertension	hypertension	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
gravida	gravida	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
para	para	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
toxemia	toxemia	NN	B-NP	O
requiring	require	VBG	B-VP	O
Cesarean	Cesarean	JJ	B-NP	O
section	section	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
and	and	CC	I-NP	O
obesity	obesity	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMIT	ADMIT	NN	I-NP	O
:	:	:	O	O
Included	Include	VBD	B-VP	O
cyclophosphamide	cyclophosphamide	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Cardura	Cardura	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Imuran	Imuran	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
prednisone	prednisone	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Vasotec	Vasotec	NNP	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Pravachol	Pravachol	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
ALLERGIES	ALLERGIES	NNS	I-NP	O
:	:	:	O	O
To	To	TO	B-PP	O
penicillin	penicillin	NN	B-NP	O
and	and	CC	I-NP	O
Sulfa	Sulfa	NNP	I-NP	O
which	which	WDT	B-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
rashes	rash	NNS	B-NP	O
.	.	.	O	O

Allergy	Allergy	NN	B-NP	O
to	to	TO	B-PP	O
intravenous	intravenous	JJ	B-NP	O
contrast	contrast	NN	I-NP	O
dye	dye	NN	I-NP	O
which	which	WDT	B-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
pruritic	pruritic	JJ	B-NP	O
hives	hive	NNS	I-NP	O
.	.	.	O	O

Morphine	Morphine	NN	B-NP	O
causing	cause	VBG	B-VP	O
nausea	nausea	NN	B-NP	O
and	and	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
and	and	CC	I-NP	O
succinylcholine	succinylcholine	NN	I-NP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
reports	report	NNS	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
respiratory	respiratory	JJ	B-NP	O
arrest	arrest	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Coronary	Coronary	NNP	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
temperature	temperature	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
102.6	102.6	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
sinus	sinus	NN	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
130s	130	NNS	I-NP	B-DNA
,	,	,	O	O
slightly	slightly	RB	B-ADJP	O
tachypneic	tachypneic	JJ	I-ADJP	O
up	up	IN	B-PP	O
to	to	TO	B-PP	O
24	24	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
98/40	98/40	CD	B-NP	O
,	,	,	O	O
already	already	RB	B-ADVP	O
on	on	IN	B-PP	O
40	40	CD	B-NP	O
mcg	mcg	NN	I-NP	O
of	of	IN	B-PP	O
Neo	Neo	NNP	B-NP	O
intravenously	intravenously	RB	B-ADVP	O
.	.	.	O	O

General	General	NNP	B-NP	O
:	:	:	O	O
Drowsy	Drowsy	NNP	B-NP	O
,	,	,	O	O
ill-appearing	ill-appearing	JJ	B-NP	O
,	,	,	I-NP	O
flush	flush	JJ	I-NP	O
young	young	JJ	I-NP	O
woman	woman	NN	I-NP	O
.	.	.	O	O

Pupils	Pupil	NNS	B-NP	O
equal	equal	JJ	I-NP	O
,	,	,	I-NP	O
round	round	JJ	I-NP	O
and	and	CC	I-NP	O
reactive	reactive	JJ	I-NP	O
to	to	TO	B-VP	O
light	light	VB	I-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Extraocular	Extraocular	JJ	B-NP	O
movements	movement	NNS	I-NP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Oropharynx	Oropharynx	NNP	B-NP	O
was	be	VBD	B-VP	O
erythematous	erythematous	JJ	B-ADJP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
slight	slight	JJ	I-NP	O
white	white	JJ	I-NP	O
exudate	exudate	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
tonsils	tonsil	NNS	I-NP	O
and	and	CC	I-NP	O
pharynx	pharynx	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Mucous	Mucous	JJ	B-NP	O
membranes	membrane	NNS	I-NP	O
were	be	VBD	B-VP	O
dry	dry	JJ	B-ADJP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
white	white	JJ	I-NP	O
,	,	,	I-NP	O
red	red	JJ	I-NP	O
exudate	exudate	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
tongue	tongue	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
tender	tender	NN	I-NP	B-protein
cervical	cervical	JJ	I-NP	I-protein
chains	chain	NNS	I-NP	I-protein
but	but	CC	O	O
not	not	RB	O	O
discrete	discrete	VB	B-VP	O
palpable	palpable	JJ	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
neck	neck	NN	I-NP	O
stiffness	stiffness	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
sinus	sinus	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
:	:	:	O	O
Clear	Clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
dullness	dullness	NN	I-NP	O
to	to	TO	B-PP	O
percussion	percussion	NN	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
Revealed	Reveal	VBD	B-VP	O
rapid	rapid	JJ	B-NP	O
but	but	CC	I-NP	O
regular	regular	JJ	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
with	with	IN	B-PP	O
positive	positive	JJ	B-NP	O
S3	S3	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
apex	apex	NN	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Soft	Soft	JJ	B-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
,	,	,	I-NP	O
normal	normal	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
diffuse	diffuse	JJ	B-NP	O
,	,	,	I-NP	O
mild	mild	JJ	I-NP	O
tenderness	tenderness	NN	I-NP	O
throughout	throughout	IN	B-ADVP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
Warm	Warm	NN	B-NP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
dorsalis	dorsalis	NN	I-NP	O
pedis	pedis	NN	I-NP	O
pulses	pulse	VBZ	B-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Hands	Hand	NNS	B-NP	O
pale	pale	VBP	B-VP	O
with	with	IN	B-PP	O
cold	cold	JJ	B-NP	O
fingers	finger	NNS	I-NP	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-ADJP	O
:	:	:	O	O
Alert	Alert	NN	B-NP	O
but	but	CC	I-NP	O
drowsy	drowsy	NN	I-NP	O
and	and	CC	O	O
oriented	orient	VBN	B-NP	O
times	time	NNS	I-NP	O
four	four	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
grossly	grossly	RB	B-ADJP	O
nonfocal	nonfocal	JJ	I-ADJP	O
.	.	.	O	O

Examination	Examination	NN	B-NP	O
was	be	VBD	B-VP	O
limited	limit	VBN	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
discomfort	discomfort	NN	I-NP	O
.	.	.	O	O

LABORATORY/X-RAY	LABORATORY/X-RAY	JJ	B-NP	O
STUDIES	STUDIES	NNS	I-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
137	137	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
5.0	5.0	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
103	103	CD	I-NP	O
,	,	,	O	O
bicarbonate	bicarbonate	NN	B-NP	O
23	23	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
46	46	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
2.8	2.8	CD	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
previous	previous	JJ	I-NP	O
baseline	baseline	NN	I-NP	O
of	of	IN	B-PP	O
1.7	1.7	CD	B-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	B-protein
92	92	CD	I-NP	I-protein
,	,	,	O	O
CK	CK	NN	B-NP	B-protein
22	22	CD	I-NP	I-protein
,	,	,	O	O
with	with	IN	B-PP	O
troponin	troponin	NN	B-NP	B-protein
0.07	0.07	CD	I-NP	I-protein
.	.	.	O	O

Last	Last	JJ	B-NP	O
cyclosporine	cyclosporine	NN	I-NP	O
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
140s	140s	CD	B-NP	O
to	to	TO	B-PP	O
260s	260s	CD	B-NP	O
.	.	.	O	O

White	White	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
7.6	7.6	CD	B-NP	O
with	with	IN	B-PP	O
68	68	CD	B-NP	O
polys	poly	NNS	I-NP	O
and	and	CC	O	O
25	25	CD	B-NP	O
bands	band	NNS	I-NP	O
.	.	.	O	O

Hemoglobin	Hemoglobin	NN	B-NP	B-protein
11.3	11.3	CD	I-NP	I-protein
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
32.4	32.4	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
157	157	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

PT	PT	NN	B-NP	B-protein
12.9	12.9	CD	I-NP	I-protein
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
1.2	1.2	CD	I-NP	I-protein
,	,	,	O	O
PTT	PTT	NN	B-NP	O
33	33	CD	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
sinus	sinus	JJ	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
at	at	IN	B-PP	O
130	130	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
axis	axis	NN	I-NP	O
incomplete	incomplete	JJ	I-NP	O
right	right	JJ	I-NP	O
bundle	bundle	NN	I-NP	O
branch	branch	NN	I-NP	O
block	block	NN	I-NP	O
with	with	IN	B-PP	O
Qs	Q	NNS	B-NP	B-DNA
in	in	IN	B-PP	O
III	III	CD	B-NP	O
and	and	CC	O	O
AVF	AVF	NN	B-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
ST-T	ST-T	NN	I-NP	O
wave	wave	NN	I-NP	O
changes	change	NNS	I-NP	O
and	and	CC	O	O
low	low	JJ	B-NP	O
volts	volt	NNS	I-NP	O
across	across	IN	B-ADVP	O
.	.	.	O	O

Portable	Portable	JJ	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
,	,	,	O	O
throat	throat	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
and	and	CC	O	O
fungal	fungal	JJ	B-NP	O
isolators	isolator	NNS	I-NP	O
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
off	off	RP	B-PRT	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
EBV	EBV	NN	B-NP	O
,	,	,	O	O
CMV-IgM	CMV-IgM	NN	B-NP	O
.	.	.	O	O

Throat	Throat	DT	B-NP	O
culture	culture	NN	I-NP	O
grew	grow	VBD	B-VP	O
out	out	RP	B-PRT	O
group	group	NN	B-NP	O
A	A	NN	I-NP	O
Strep	Strep	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
improvement	improvement	NN	I-NP	O
with	with	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
and	and	CC	I-NP	O
briefly	briefly	NN	I-NP	O
received	receive	VBD	B-VP	O
vancomycin	vancomycin	NN	B-NP	O
and	and	CC	I-NP	O
gentamicin	gentamicin	NN	I-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
prior	prior	JJ	I-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
culture	culture	NN	I-NP	O
growing	grow	VBG	B-VP	O
out	out	RP	B-PRT	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
worsening	worsen	VBG	I-VP	O
renal	renal	JJ	B-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
likely	likely	RB	B-ADJP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
acute	acute	JJ	B-NP	O
tubular	tubular	JJ	I-NP	O
necrosis	necrosis	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
prerenal	prerenal	JJ	B-NP	O
azotemia	azotemia	NN	I-NP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
initial	initial	JJ	I-NP	O
hypotensive	hypotensive	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
briefly	briefly	RB	B-ADVP	O
with	with	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
and	and	CC	I-NP	O
gentamicin	gentamicin	NN	I-NP	O
.	.	.	O	O

Throat	Throat	DT	B-NP	O
culture	culture	NN	I-NP	O
grew	grow	VBD	B-VP	O
out	out	RP	B-PRT	O
group	group	NN	B-NP	O
A	A	NNP	I-NP	O
Streptococcus	Streptococcus	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
improved	improve	VBD	B-VP	O
on	on	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-NP	O
function	function	NN	I-NP	O
worsened	worsen	VBD	B-VP	O
likely	likely	RB	B-ADJP	O
due	due	JJ	I-ADJP	O
to	to	TO	B-PP	O
acute	acute	JJ	B-NP	O
tubular	tubular	JJ	I-NP	O
necrosis	necrosis	NN	I-NP	O
of	of	IN	B-PP	O
prerenal	prerenal	JJ	B-NP	O
azotemia	azotemia	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
initial	initial	JJ	I-NP	O
hypotensive	hypotensive	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
gradually	gradually	RB	B-ADVP	O
improved	improve	VBD	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
1.7	1.7	CD	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
mild	mild	JJ	I-NP	O
to	to	TO	B-PP	O
moderate	moderate	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
vigorous	vigorous	JJ	B-NP	O
intravenous	intravenous	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
resuscitation	resuscitation	NN	I-NP	O
and	and	CC	O	O
support	support	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
with	with	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
20	20	CD	I-NP	O
to	to	TO	I-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
intravenously	intravenously	RB	B-VP	O
q.d.	q.d.	VBN	I-VP	O
for	for	IN	B-PP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
with	with	IN	B-PP	O
excellent	excellent	JJ	B-NP	O
response	response	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
below	below	IN	B-PP	O
her	her	PRP$	B-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
with	with	IN	B-PP	O
nausea	nausea	NN	B-NP	O
and	and	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
was	be	VBD	B-VP	O
presumptively	presumptively	RB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Flagyl	Flagyl	NN	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
Clostridium	Clostridium	NN	B-NP	O
difficile	difficile	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-NP	O
times	time	NNS	I-NP	O
two	two	CD	B-NP	O
.	.	.	O	O

Ova	Ova	NN	B-NP	B-protein
and	and	CC	I-NP	O
parasites	parasite	NNS	I-NP	O
,	,	,	O	O
fecaliths	fecalith	NNS	B-NP	O
and	and	CC	O	O
stool	stool	NN	B-NP	O
cultures	culture	NNS	I-NP	O
were	be	VBD	B-VP	O
all	all	DT	O	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
received	receive	VBD	B-VP	O
symptomatic	symptomatic	JJ	B-NP	O
relief	relief	NN	I-NP	O
with	with	IN	B-PP	O
Compazine	Compazine	NN	B-NP	O
and	and	CC	I-NP	O
Imodium	Imodium	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
baseline	baseline	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
reappeared	reappear	VBD	B-VP	O
after	after	IN	B-PP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
had	have	VBD	B-VP	O
stabilized	stabilize	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
Vasotec	Vasotec	NNP	B-NP	O
and	and	CC	I-NP	O
Cardura	Cardura	NNP	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
been	be	VBN	I-VP	O
evidently	evidently	RB	B-ADJP	O
longstanding	longstanding	JJ	I-ADJP	O
and	and	CC	O	O
well	well	RB	B-ADJP	O
tolerated	tolerate	VBN	I-ADJP	O
with	with	IN	B-PP	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
100	100	CD	B-NP	B-DNA
to	to	TO	B-PP	I-DNA
120s	120s	CD	B-NP	I-DNA
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
in	in	IN	B-PP	O
good	good	JJ	B-NP	O
condition	condition	NN	I-NP	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
#	#	#	B-NP	O
5	5	CD	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
ten-day	ten-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
at	at	IN	B-PP	O
renal	renal	JJ	B-NP	O
dose	dose	NN	I-NP	O
,	,	,	O	O
250	250	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
also	also	RB	B-ADVP	O
continued	continue	VBD	B-VP	O
her	her	PRP	B-NP	O
usual	usual	JJ	I-NP	O
immunosuppressive	immunosuppressive	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
cyclosporine	cyclosporine	NN	I-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
454	454	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
follow-up	follow-up	JJ	I-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Tucay	Tucay	NNP	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Discharge	Discharge	NN	B-NP	O
medications	medication	NNS	I-NP	O
included	include	VBD	B-VP	O
Imuran	Imuran	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Sandimmune	Sandimmune	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Vasotec	Vasotec	NNP	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Miracle	Miracle	NNP	B-NP	O
Cream	Cream	NNP	I-NP	O
topically	topically	RB	B-ADVP	O
q.d.	q.d.	RB	I-ADVP	O
,	,	,	O	O
prednisone	prednisone	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
Zantac	Zantac	NN	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Cardura	Cardura	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Compazine	Compazine	NN	B-NP	O
5	5	CD	I-NP	O
to	to	TO	I-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
q.4-6h	q.4-6h	NN	I-NP	O
.	.	.	O	O

prn	prn	NN	B-NP	O
nausea	nausea	NN	I-NP	O
and	and	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
,	,	,	O	O
Pepto-Bismol	Pepto-Bismol	NN	B-NP	O
30	30	CD	I-NP	O
ml	ml	NN	I-NP	O
q.	q.	NN	I-NP	O
1h	1h	NN	I-NP	O
.	.	.	O	O

prn	prn	NN	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
up	up	IN	B-PP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
eight	eight	CD	B-NP	O
doses	dose	NNS	I-NP	O
in	in	IN	B-PP	O
24	24	CD	B-NP	O
hours	hour	NNS	I-NP	O
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
ten-day	ten-day	JJ	B-NP	O
course	course	NN	I-NP	O
,	,	,	O	O
Imodium	Imodium	NN	B-NP	O
2	2	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	CD	I-NP	O
prn	prn	NN	I-NP	O
diarrhea	diarrhea	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
prn	prn	NN	I-NP	O
increased	increase	VBD	B-VP	O
weight	weight	NN	B-NP	O
by	by	IN	B-PP	O
two	two	CD	B-NP	O
pounds	pound	NNS	I-NP	O
above	above	IN	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
weight	weight	NN	I-NP	O
of	of	IN	B-PP	O
99	99	CD	B-NP	O
kg	kg	NN	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
VAN	VAN	NNP	B-NP	O
HAKER	HAKER	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
UI90	UI90	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
WG476/4530	WG476/4530	NNP	B-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
86327	86327	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

V2HS1W1918	V2HS1W1918	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
11/1	11/1	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
8/25	8/25	CD	B-NP	O

